|
|
Home
Life Sciences
Pharma
Anticancer
Disease 
Contact us to find out if we have the data
you need. Having offices around the globe, we are open 24 hours a day, 5 days a week with multiple
language support. Please visit our Contact page
to see which office is open right now!
|
| AVAILABLE PRODUCTS |
| Title |
Publish Date |
Type |
Stakeholder Opinions: Hepatocellular Carcinoma - Growing Market Seeks New Players
Hepatocellular carcinoma (HCC) is the fifth commonest cancer worldwide with ca. one million new cases diagnosed annually. Datamonitor estimates that the incidence of HCC in more…
|
Sep 30, 2004 |
Market Research Report |
Pipeline Insight: Alzheimer's Disease - A Busy Future, with Diagnosis, Disease Modification and Prevention Key to Growing Market
Epidemiology of Alzheimer's Disease across the 7 major markets, as well as analysis of the main unmet needs in the current treatment of the disease more…
|
Jul 02, 2004 |
Market Research Report |
Landmark Anti-dyslipidemic Trials Update - How Low Can You Go?
The Heart Protection Study showed that patients with "normal" LDL cholesterol, as defined by the NCEP guidelines, experienced equal benefit from LDL cholesterol reduction as more…
|
Jun 23, 2004 |
Market Research Report |
Overview of Autoimmune Disease Research
Overview of Autoimmune Disease Research provides a top-level view of the science being conducted in leading immunology labs. more…
|
Jun 14, 2004 |
Market Research Report |
Commercial Insight: Hepatitis B and C - Awaiting New Developments
The launch of the pegylated interferons has had a dramatic effect on the market for hepatitis treatments, with the improvements in side-effect profile and efficacy leading to more…
|
Jun 11, 2004 |
Market Research Report |
|
|
|
|
|